A combination product comprising melagatran and a factor Xa inhibitor for anticoagulant therapy

摘要

A combination product comprises (a) melagatran and (b) a Factor Xa inhibitor where each of (a) and (b) are formulated in admixture with a pharmaceutically-acceptable adjuvant and are present in synergistically anticoagulant effective amounts. The combination product can be used in the manufacture of a medicament for the treatment or prophylaxis of a condition where anticoagulant therapy is required.